{"database": "lobbying", "table": "lobbying_activities", "rows": [[1996492, "4cd9c9d2-c6f6-4286-b5ea-56a089243e18", "Q2", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)", 2017, "second_quarter", "PHA", "Importation of prescription drugs (S. 469, S. 771, H.R. 1776, H.R. 1245, H.R. 934, H.R. 1480, S. 92, S. 64)\nRx Pedigree (PL 113-54)\nPrescription Drug Monitoring Programs (S. 480, H.R. 1725)\nPrescription Drug Abuse - General issues related to Rx drug abuse \nEnsuring Patient Access and Effective Enforcement Act (PL 114-145)\nImplementation of Public Law 113-54 (DSCSA)", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 80000, null, 0, 0, "2017-07-19T13:46:40.697000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1996492"], "units": {}, "query_ms": 34.56663998076692, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}